?:authorAffiliation
|
-
[\'GSK, Singapore, Singapore. Electronic address: philippe.x.buchy@gsk.com.\', \'Académie nationale de médecine, Paris, France. Electronic address: yvesbuisson@hotmail.com.\', \'GSK, Rio de Janeiro, Brazil. Electronic address: otavio.a.cintra@gsk.com.\', \'New South Wales Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales, Australia. Electronic address: dominic.dwyer@sydney.edu.au.\', \'Consultant in Infectious Diseases, University of Queensland, Brisbane, Australia. Electronic address: theniss@uq.edu.au.\', \'Scientific Advisor & Emeritus director at Valladolid NIC (National Influenza Centre) Spain, School of Medicine, Avd Ramón y Cajal s/n 47005 Valladolid, Spain. Electronic address: lejarazu@gmail.com.\', \'European Society for Clinical Microbiology and Infectious Diseases, Basel, Switzerland; Department of Molecular Medicine, The University of Pavia, Pavia, Italy; Department of Clinical, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: eskild.petersen@gmail.com.\']
|